Literature DB >> 6696816

Prospects for the future in the management of carcinoma of the breast: the biological fall out from clinical trials.

M Baum.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6696816      PMCID： PMC1976697          DOI： 10.1038/bjc.1984.22

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  14 in total

1.  Treatment and survival on advanced breast cancer.

Authors:  T Priestman; M Baum; V Jones; J Forbes
Journal:  Br Med J       Date:  1978-12-16

2.  The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 "negative" trials.

Authors:  J A Freiman; T C Chalmers; H Smith; R R Kuebler
Journal:  N Engl J Med       Date:  1978-09-28       Impact factor: 91.245

3.  Macrophage production by the bone marrow of tumor-bearing mice.

Authors:  M Baum; B Fisher
Journal:  Cancer Res       Date:  1972-12       Impact factor: 12.701

4.  Dose-response effect of adjuvant chemotherapy in breast cancer.

Authors:  G Bonadonna; P Valagussa
Journal:  N Engl J Med       Date:  1981-01-01       Impact factor: 91.245

5.  Low incidence of estrogen receptor in breast carcinomas with rapid rates of cellular replication.

Authors:  J S Meyer; B R Rao; S C Stevens; W L White
Journal:  Cancer       Date:  1977-11       Impact factor: 6.860

6.  Platelet-dependent stimulation of prostacyclin synthesis by platelet-derived growth factor.

Authors:  S R Coughlin; M A Moskowitz; B R Zetter; H N Antoniades; L Levine
Journal:  Nature       Date:  1980-12-11       Impact factor: 49.962

7.  THE SIGNIFICANCE OF REGIONAL LUMPH NODE METASTASES IN BREAST CARCINOMA.

Authors:  J E DEVITT
Journal:  Can Med Assoc J       Date:  1965-08-14       Impact factor: 8.262

8.  Ovarian function in patients receiving adjuvant chemotherapy for breast cancer.

Authors:  D P Rose; T E Davis
Journal:  Lancet       Date:  1977-06-04       Impact factor: 79.321

9.  The contribution of recent NSABP clinical trials of primary breast cancer therapy to an understanding of tumor biology--an overview of findings.

Authors:  B Fisher; C Redmond; E R Fisher
Journal:  Cancer       Date:  1980-08-15       Impact factor: 6.860

10.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1976-12       Impact factor: 7.640
View more
  3 in total

1.  Skeletal effects of carcinoma of the breast and prostate.

Authors:  R C Percival
Journal:  Ann R Coll Surg Engl       Date:  1986-09       Impact factor: 1.891

2.  Six-year results of a controlled trial of tamoxifen as single adjuvant agent in management of early breast cancer.

Authors:  A J Wilson; M Baum; D M Brinkley; J A Dossett; K McPherson; J S Patterson; R D Rubens; F G Smiddy; B A Stoll; D Richards
Journal:  World J Surg       Date:  1985-10       Impact factor: 3.352

Review 3.  Progress in understanding breast cancer: epidemiological and biological interactions.

Authors:  P Boyle; R Leake
Journal:  Breast Cancer Res Treat       Date:  1988-05       Impact factor: 4.872
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.